These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19502537)

  • 1. Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study.
    Pitocco D; Zelano G; Gioffrè G; Di Stasio E; Zaccardi F; Martini F; Musella T; Scavone G; Galli M; Caputo S; Mancini L; Ghirlanda G
    Diabetes Care; 2009 Sep; 32(9):1694-7. PubMed ID: 19502537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.
    Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G
    Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis.
    Peng Y; Sheng X; Xue F; Qian Y
    Medicine (Baltimore); 2018 Dec; 97(51):e13507. PubMed ID: 30572450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Osteoprotegerin and Charcot Neuroarthropathy: a systematic review.
    Ochoa-Précoma R; Pacheco-Soto BT; Porchia LM; Torres-Rasgado E; Pérez-Fuentes R; Gonzalez-Mejia ME
    Acta Diabetol; 2021 Apr; 58(4):475-484. PubMed ID: 33394132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
    Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
    Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcot Pathogenesis: A Study of In Vivo Gene Expression.
    Connors JC; Hardy MA; Kishman LL; Botek GG; Verdin CJ; Rao NM; Kingsley JD
    J Foot Ankle Surg; 2018; 57(6):1067-1072. PubMed ID: 30368423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process.
    Araszkiewicz A; Soska J; Borucka K; Olszewska M; Niedzwiecki P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2015 Sep; 101():143-7. PubMed ID: 26239695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes.
    Biscetti F; Porreca CF; Bertucci F; Straface G; Santoliquido A; Tondi P; Angelini F; Pitocco D; Santoro L; Gasbarrini A; Landolfi R; Flex A
    Acta Diabetol; 2014 Dec; 51(6):1025-32. PubMed ID: 25323324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy.
    Young MJ; Marshall A; Adams JE; Selby PL; Boulton AJ
    Diabetes Care; 1995 Jan; 18(1):34-8. PubMed ID: 7698045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients.
    Biscetti F; Straface G; Giovannini S; Santoliquido A; Angelini F; Santoro L; Porreca CF; Pecorini G; Ghirlanda G; Flex A
    Hum Genet; 2013 Jan; 132(1):49-55. PubMed ID: 22965192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women?
    Zajíčková K; Zemanová A; Hill M; Žofková I
    Physiol Res; 2008; 57 Suppl 1():S153-S157. PubMed ID: 18271681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Mol Biol Rep; 2010 Jan; 37(1):227-34. PubMed ID: 19642016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis.
    Lanting SM; Chan TL; Casey SL; Peterson BJ; Chuter VH
    J Foot Ankle Res; 2022 Mar; 15(1):17. PubMed ID: 35232466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin SNP associations with coronary artery disease and ischemic stroke risk: a meta-analysis.
    Wu J; Li X; Gao F; Gao S; Lyu J; Qiang H
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of genetic factors and monocyte-to-osteoclast differentiation in the pathogenesis of Charcot neuroarthropathy.
    Kloska A; Korzon-Burakowska A; Malinowska M; Bruhn-Olszewska B; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
    Diabetes Res Clin Pract; 2020 Aug; 166():108337. PubMed ID: 32707214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development.
    Bruhn-Olszewska B; Korzon-Burakowska A; Węgrzyn G; Jakóbkiewicz-Banecka J
    Sci Rep; 2017 Mar; 7(1):501. PubMed ID: 28356555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients.
    Guo C; Hu F; Zhang S; Wang Y; Liu H
    Genet Mol Biol; 2013 Jul; 36(2):177-82. PubMed ID: 23885198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.